Drug Shortage Report for ZOLOFT
Report ID | 173305 |
Drug Identification Number | 01962779 |
Brand name | ZOLOFT |
Common or Proper name | ZOLOFT |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SERTRALINE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-10-15 |
Estimated end date | |
Actual end date | 2022-11-30 |
Shortage status | Resolved |
Updated date | 2023-01-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-01-17 | French | Compare |
v3 | 2023-01-17 | English | Compare |
v2 | 2022-11-02 | French | Compare |
v1 | 2022-11-02 | English | Compare |
Showing 1 to 4 of 4